{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:52:15Z","timestamp":1791499935036,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bmcl.2025.130163","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:46:37Z","timestamp":1740969997000},"page":"130163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Synthesis, antiproliferative activity, and biological profiling of C-19 trityl and silyl ether andrographolide analogs in colon cancer and breast cancer cells"],"prefix":"10.1016","volume":"121","author":[{"given":"Tiffany","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushika","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Bashkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyuk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyeon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bhaskara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samarth","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samahith","family":"Thellakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Jayabalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Njoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drudis.2015.01.009","article-title":"An analysis of FDA-approved drugs: natural products and their derivatives","volume":"21","author":"Patridge","year":"2016","journal-title":"Drug Discov Today"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130163_bb0015","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Nat Prod Rep"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130163_bb0020","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol Adv"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130163_bb0030","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1021\/cr900019j","article-title":"Impact of natural products on developing new anti-Cancer agents","volume":"109","author":"Cragg","year":"2009","journal-title":"Chem Rev"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/a902202c","article-title":"The influence of natural products upon drug discovery (antiquity to late 1999)","volume":"17","author":"Newman","year":"2000","journal-title":"Nat Prod Rep"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130163_bb0040","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jnatprod.4c00581","article-title":"Natural products have increased rates of clinical trial success throughout the drug development process","volume":"87","author":"Domingo-Fern\u00e1ndez","year":"2024","journal-title":"J Nat Prod"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130163_bb0045","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/biomedicines9060689","article-title":"Natural products, alone or in combination with FDA-approved drugs, to treat COVID-19 and lung Cancer","volume":"9","author":"Yang","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130163_bb0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/CAD.0000000000000063","article-title":"Nature as a remarkable chemist","volume":"25","author":"Wani","year":"2014","journal-title":"Anti-Cancer Drugs"},{"issue":"8 Pt 1","key":"10.1016\/j.bmcl.2025.130163_bb0055","first-page":"2597","article-title":"Pharmacokinetics and metabolism of vinblastine in humans","volume":"37","author":"Owellen","year":"1977","journal-title":"Cancer Res"},{"issue":"7041","key":"10.1016\/j.bmcl.2025.130163_bb0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature03566","article-title":"Structural basis for the regulation of tubulin by vinblastine","volume":"435","author":"Gigant","year":"2005","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130163_bb0065","article-title":"Differential activity of vincristine and vinblastine against cultured cells","volume":"44","author":"Ferguson","year":"1984","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/10428194.2019.1660970","article-title":"CPX-351 (vyxeos) in AML","volume":"61","author":"Alfayez","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bmcl.2025.130163_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130163_bb0080","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/ph16101456","article-title":"Prospects of topoisomerase inhibitors as promising anti-Cancer agents","volume":"16","author":"Yakkala","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130163_bb0085","doi-asserted-by":"crossref","first-page":"11961","DOI":"10.1021\/acs.joc.7b02088","article-title":"The difference a single atom can make: synthesis and design at the chemistry\u2013biology interface","volume":"82","author":"Boger","year":"2017","journal-title":"J Organomet Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0090","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.apsb.2023.11.021","article-title":"Late-stage modification of bioactive compounds: improving druggability through efficient molecular editing","volume":"14","author":"Huo","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmcl.2025.130163_bb0095","first-page":"79","article-title":"Structure-activity relationships of Taxol and Taxotere analogues","volume":"15","author":"Gu\u00e9nard","year":"1993","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.bmcl.2025.130163_bb0100","first-page":"4845","article-title":"Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue","volume":"51","author":"Bissery","year":"1991","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0305-7372(96)90032-8","article-title":"Vinorelbine: an overview","volume":"22","author":"Johnson","year":"1996","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002512-199915010-00006","article-title":"Valrubicin","volume":"15","author":"Onrust","year":"1999","journal-title":"Drugs Aging"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130163_bb0115","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/14737140.2015.1115350","article-title":"Valrubicin in refractory non-muscle invasive bladder cancer","volume":"15","author":"Sharma","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130163_bb0120","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1039\/C7SC01248A","article-title":"Indole diterpenoid natural products as the inspiration for new synthetic methods and strategies","volume":"8","author":"Corsello","year":"2017","journal-title":"Chem Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acs.jnatprod.7b00799","article-title":"Anti-inflammatory Grayanane Diterpenoids from the leaves of Rhododendron molle","volume":"81","author":"Zhou","year":"2018","journal-title":"J Nat Prod"},{"issue":"40","key":"10.1016\/j.bmcl.2025.130163_bb0130","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1002\/slct.202002836","article-title":"Diterpenoids: natural distribution, Semisynthesis at room temperature and pharmacological aspects-a decade update","volume":"5","author":"Majhi","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2025.130163_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ejmech.2019.05.022","article-title":"Andrographolide: a natural product template for the generation of structurally and biologically diverse diterpenes","volume":"176","author":"Kandanur","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130163_bb0140","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3390\/plants12101969","article-title":"Anti-Cancer agent: the Labdane Diterpenoid-Andrographolide","volume":"12","author":"Tundis","year":"2023","journal-title":"Plants"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2222-1808(14)60509-0","article-title":"Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: a review of its phytochemistry and pharmacology","volume":"4","author":"Okhuarobo","year":"2014","journal-title":"Asian Pac J Trop Dis"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130163_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/13596535231207499","article-title":"Andrographolide inhibits infectious bronchitis virus-induced apoptosis, pyroptosis, and inflammation","volume":"28","author":"Shen","year":"2023","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bmcl.2025.130163_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112481","article-title":"From irreversible to reversible covalent inhibitors: harnessing the andrographolide scaffold for anti-inflammatory action","volume":"204","author":"Tran","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130163_bb0160","article-title":"A comprehensive review of Andrographis paniculata (Burm. F.) Nees and its constituents as potential Lead compounds for COVID-19 drug discovery","volume":"27(14):4479","author":"Intharuksa","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12883-016-0595-2","article-title":"Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study","volume":"16","author":"Bertoglio","year":"2016","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/np5007179","article-title":"Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-\u03baB p50","volume":"78","author":"Nguyen","year":"2015","journal-title":"J Nat Prod"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130163_bb0200","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.4049\/jimmunol.173.6.4207","article-title":"Andrographolide attenuates inflammation by inhibition of NF-\u03baB activation through covalent modification of reduced cysteine 62 of p50","volume":"173","author":"Xia","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130163_bb0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1039\/D0NP00049C","article-title":"Polypharmacology of andrographolide: beyond one molecule one target","volume":"38","author":"Tran","year":"2021","journal-title":"Nat Prod Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/molecules26010005","article-title":"Andrographolide, an anti-inflammatory multitarget drug: all roads Lead to cellular metabolism","volume":"26","author":"Burgos","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0215","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1038\/s41598-024-57304-7","article-title":"Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K\/AKT signalling pathway","volume":"14","author":"Pasha","year":"2024","journal-title":"Sci Rep"},{"issue":"49","key":"10.1016\/j.bmcl.2025.130163_bb0220","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-\u03baB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0225","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728220903431069","article-title":"The NF-\u03baB activation pathways, emerging molecular targets for cancer prevention and therapy","volume":"14","author":"Lin","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmcl.2025.130163_bb0240","first-page":"12","article-title":"Natural small molecules targeting NF-\u03baB signaling in glioblastoma","author":"Uddin","year":"2021","journal-title":"Front Pharmacol"},{"issue":"14","key":"10.1016\/j.bmcl.2025.130163_bb0245","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.3390\/ijms21145164","article-title":"Small molecule NF-\u03baB pathway inhibitors in clinic","volume":"21","author":"Ramadass","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11\u221212","key":"10.1016\/j.bmcl.2025.130163_bb0250","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1080\/01635581.2020.1828942","article-title":"Andrographolide induces apoptosis and cell cycle arrest through inhibition of aberrant hedgehog signaling pathway in Colon Cancer cells","volume":"73","author":"Khan","year":"2021","journal-title":"Nutr Cancer"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130163_bb0255","first-page":"2845","article-title":"Inhibition of topoisomerase II\u03b1 and induction of apoptosis in gastric Cancer cells by 19-Triisopropyl Andrographolide","volume":"18","author":"Monger","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130163_bb0260","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.drudis.2019.05.017","article-title":"Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents","volume":"24","author":"Soo","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2025.130163_bb0265","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.biopha.2018.02.119","article-title":"A silyl andrographolide analogue suppresses Wnt\/\u03b2-catenin signaling pathway in colon cancer","volume":"101","author":"Reabroi","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26278-8","article-title":"The anti-cancer activity of an andrographolide analogue functions through a GSK-3\u03b2-independent Wnt\/\u03b2-catenin signaling pathway in colorectal cancer cells","volume":"8","author":"Reabroi","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2013.12.002","article-title":"Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition","volume":"723","author":"Nateewattana","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130163_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111885","article-title":"Cytoplasmic and\/or nuclear expression of \u03b2-catenin correlate with poor prognosis and unfavorable Clinicopathological factors in hepatocellular carcinoma: a Meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0295","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.5056","article-title":"Therapeutic strategies targeting Wnt\/\u03b2-catenin signaling for colorectal cancer (review)","volume":"49","author":"Ji","year":"2021","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130163_bb0305","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ijc.10719","article-title":"Cytoplasmic and\/or nuclear accumulation of the \u03b2-catenin protein is a frequent event in human osteosarcoma","volume":"102","author":"Haydon","year":"2002","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130163_bb0310","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1021\/acs.jmedchem.7b00718","article-title":"Quest for novel chemical entities through incorporation of silicon in drug scaffolds","volume":"61","author":"Ramesh","year":"2018","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130163_bb0315","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1200\/JCO.2000.18.9.1967","article-title":"Biology of the adenomatous polyposis coli tumor suppressor","volume":"18","author":"Goss","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0320","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yexcr.2016.01.020","article-title":"Characterization of a beta-catenin nuclear localization defect in MCF-7 breast cancer cells","volume":"341","author":"Jamieson","year":"2016","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bmcl.2025.130163_bb0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1025944723047","article-title":"Beta-catenin and Tcfs in mammary development and cancer","author":"Hatsell","year":"2003","journal-title":"J Mammary Gland Biol Neoplasia Published online"},{"issue":"5307","key":"10.1016\/j.bmcl.2025.130163_bb0330","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of \u03b2-catenin-Tcf signaling in Colon Cancer by mutations in \u03b2-catenin or APC","volume":"275","author":"Morin","year":"1979","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0335","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/1471-2407-10-414","article-title":"Nuclear \u03b2-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells","volume":"10","author":"Uchino","year":"2010","journal-title":"BMC Cancer"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130163_bb0340","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.yexcr.2013.10.002","article-title":"Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of \u03b2-catenin\/connexin43 association","volume":"319","author":"Talhouk","year":"2013","journal-title":"Exp Cell Res"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0345","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr2317","article-title":"WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB 231 xenograft growth","volume":"11","author":"Matsuda","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bmcl.2011.11.085","article-title":"New substituted C-19-andrographolide analogues with potent cytotoxic activities","volume":"22","author":"Sirion","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130163_bb0355","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/jm3010114","article-title":"Organosilicon molecules with medicinal applications","volume":"56","author":"Franz","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130163_bb0360","doi-asserted-by":"crossref","DOI":"10.1039\/D4MD00169A","article-title":"The role of silicon in drug discovery: a review","author":"Panayides","year":"2024","journal-title":"RSC Med Chem Published online"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130163_bb0365","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1021\/acs.jmedchem.9b00146","article-title":"Expanding the chemical space of Withaferin a by incorporating silicon to improve its clinical potential on human ovarian carcinoma cells","volume":"62","author":"Perestelo","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130163_bb0370","article-title":"Design and synthesis of mycophenolic acid analogues for osteosarcoma Cancer treatment","volume":"17","author":"Silalai","year":"2024","journal-title":"ACS Bio & Med Chem Au Published online October"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130163_bb0375","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1021\/acs.jmedchem.9b01030","article-title":"Structural basis for achieving GSK-3\u03b2 inhibition with high potency, selectivity, and brain exposure for positron emission tomography imaging and drug discovery","volume":"62","author":"Bernard-Gauthier","year":"2019","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130163_bb0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1756-0500-7-273","article-title":"Cytotoxicity and activation of the Wnt\/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors","volume":"7","author":"Naujok","year":"2014","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130163_bb0390","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130163_bb0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J Microsc"},{"issue":"28","key":"10.1016\/j.bmcl.2025.130163_bb0400","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.1205015109","article-title":"Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130163_bb0405","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bpj.2019.09.009","article-title":"AdipoRon attenuates Wnt signaling by reducing cholesterol-dependent plasma membrane rigidity","volume":"118","author":"Salinas","year":"2020","journal-title":"Biophys J"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:30:16Z","timestamp":1777642216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":76,"alternative-id":["S0960894X25000721"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130163","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2024-lrkln","asserted-by":"object"}]},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, antiproliferative activity, and biological profiling of C-19 trityl and silyl ether andrographolide analogs in colon cancer and breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130163"}}